DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Suicide Treatment and Recovery in Integrated Behavioral Health (STRIBH)

Not Applicable

Not yet recruiting

Conditions: Suicidal Ideation and Behavior

First Posted Date: 2024-11-22

Last Posted Date: 2024-12-02

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT06700993

Daily Doxycycline for Early Syphillis

Phase 2

Recruiting

Conditions: Syphilis

Interventions: Drug: Doxycycline 200mg daily for 14 days

First Posted Date: 2024-11-12

Last Posted Date: 2025-03-07

Lead Sponsor: University of Washington

Target Recruit Count: 15

Registration Number: NCT06683638

Locations: 🇺🇸
Public Health Sexual Health Clinic, Seattle, Washington, United States

Individual Factors of CBT Underlying Success

Not Applicable

Recruiting

Conditions: Social Anxiety Disorder
Body Dysmorphic Disorder

First Posted Date: 2024-11-07

Last Posted Date: 2024-11-07

Lead Sponsor: University of Washington

Target Recruit Count: 160

Registration Number: NCT06678295

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

BASIS Optimization

Not Applicable

Recruiting

Conditions: Mental Health
Health Services
Evidence Based Programs in Schools

First Posted Date: 2024-11-04

Last Posted Date: 2024-11-04

Lead Sponsor: University of Washington

Target Recruit Count: 32

Registration Number: NCT06672835

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: Lidocaine
Procedure: Biopsy of Prostate
Other: Questionnaire Administration

First Posted Date: 2024-10-28

Last Posted Date: 2025-02-03

Lead Sponsor: University of Washington

Target Recruit Count: 300

Registration Number: NCT06661902

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

Phase 4

Recruiting

Conditions: Acute Spinal Cord Injury

Interventions: Drug: Perflutren lipid

First Posted Date: 2024-10-23

Last Posted Date: 2025-04-27

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT06654804

Locations: 🇺🇸
University of Washington Harborview Medical Center, Seattle, Washington, United States

CBT Vs. Supportive Texts for PTSD & Hazardous Drinking (Project Better Study 2)

Not Applicable

Recruiting

Conditions: Alcohol Use
Posttraumatic Stress Disorder

First Posted Date: 2024-10-18

Last Posted Date: 2024-11-21

Lead Sponsor: University of Washington

Target Recruit Count: 333

Registration Number: NCT06648395

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

Phase 1

Recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm
Metastatic Malignant Solid Neoplasm

Interventions: Behavioral: Behavioral Intervention
Behavioral: Group Therapy
Drug: Psilocybin
Other: Questionnaire Administration

First Posted Date: 2024-10-16

Last Posted Date: 2025-01-31

Lead Sponsor: University of Washington

Target Recruit Count: 16

Registration Number: NCT06644170

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

One-step HCV RNA Testing Among SSP Participants (HOT Study)

Not Applicable

Not yet recruiting

Conditions: Testing Effect of Intervention

Interventions: Diagnostic Test: HCV RNA Rapid testing

First Posted Date: 2024-10-09

Last Posted Date: 2024-10-09

Lead Sponsor: University of Washington

Target Recruit Count: 227

Registration Number: NCT06634342

Prevention and Treatment of Common Hyperglycemia in Surgery

Phase 4

Conditions: Surgery
Non Diabetic Hyperglycemia

Interventions: Drug: Crystalloid Infusion
Drug: glucose, insulin, and potassium (GIK)

First Posted Date: 2024-10-03

Last Posted Date: 2025-01-30

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT06624956

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy